Five stocks stand out heading into Monday, September 28, 2026, each carrying a bullish rating change issued on Friday, September 25. Rates remain the dominant market story. The Federal Open Market Committee raised the federal funds target range to 3.75% to 4.00% on September 16, and the CME Group FedWatch tool priced the odds of another increase at the October 27-28 meeting at 77.5% on September 24. The next major data point arrives on September 30, when the Bureau of Economic Analysis releases August Personal Consumption Expenditures inflation, the Fed's preferred gauge.
The five ideas below span chip-design software, managed care, climate-control equipment, nitrogen fertilizer, and river and ocean cruising. Editorial notes only, not investment advice.
Synopsys (SNPS) – HSBC Makes an Aggressive Call on Chip-Design Software
Synopsys was upgraded from Hold to Buy on Friday by HSBC analyst Stephen Bersey, who raised his price target to $700 from $490. That new target ties the high end of the panel. Synopsys supplies the electronic design automation software that chipmakers use to design processors, and demand for custom AI silicon keeps design activity elevated.
Shares traded near $428.69 during Friday's session, up about 0.89%, giving Synopsys a market capitalization near $82 billion. The 52-week range runs from $362.55 to $539.48, and the trailing price-to-earnings multiple sits at 75.19.
Sentiment has turned sharply this month. Morgan Stanley's Lee Simpson upgraded to Overweight on September 8, and Wells Fargo's Joe Quatrochi followed on September 10. Consensus now reads strong buy, with 15 of 16 tracked ratings bullish. The average price target of $573.12 implies roughly 34% upside.
Risks: A premium multiple leaves little room for disappointment, and higher rates weigh on long-duration growth stocks. Piper Sandler's Clarke Jeffries downgraded to Neutral in January and cut his target to $430 in February. Integration of prior acquisitions and export restrictions on China sales all remain factors to monitor.
Humana (HUM) – Barclays Upgrades After a Sharp Recovery
Humana was upgraded from Equal-Weight to Overweight on Friday by Barclays analyst Andrew Mok, who raised his price target to $515 from $407. Humana is one of the largest Medicare Advantage insurers, and the stock has more than doubled from its 52-week low as investors regained confidence in pricing and cost trends.
Shares traded near $403.36 during Friday's session, up about 6.06%, giving Humana a market capitalization near $48 billion. The 52-week range runs from $163.11 to $428.88, and the trailing price-to-earnings multiple sits at 38.24.
The broader panel has not caught up. Consensus reads buy, with eight bullish, nine neutral, and one bearish rating among 18 tracked firms. The average price target of $379.72 sits below the current price, while the Barclays target implies roughly 28% upside.
Risks: The rally has already priced in much of the recovery. JPMorgan's Lisa Gill holds Neutral at $393, and Morgan Stanley's Erin Wright moved only to Equal-Weight at $370 on August 5. Medicare Advantage reimbursement rates, star ratings, and medical-cost trends all remain factors to monitor.
Trane Technologies (TT) – Wells Fargo Initiates at Overweight
Trane Technologies drew a fresh Overweight initiation on Friday from Wells Fargo, part of a broad industrials launch that also covered Eaton, Emerson, Dover, Johnson Controls, Vertiv, and Carrier. Trane makes heating, ventilation, and air-conditioning systems, and data-center cooling has become a meaningful growth driver alongside commercial building demand.
Shares traded near $453.19 during Friday's session, up about 3.34%, giving Trane a market capitalization near $100 billion. The 52-week range runs from $348.06 to $505.87, and the trailing price-to-earnings multiple sits at 34.38.
Consensus reads buy, with nine bullish, two neutral, and one bearish rating among 12 tracked firms. The average price target of $523.83 implies roughly 16% upside. Bernstein's Varun Govindaraj raised his target to $575 on August 14 with Outperform.
Risks: Wells Fargo's prior coverage carried Underweight at $400 in January, a reminder of how quickly views on the name can swing. RBC Capital's Deane Dray holds Sector Perform at $496. Residential HVAC softness and the pace of data-center spending all remain factors to monitor.
CF Industries (CF) – Bernstein Initiates at Outperform
CF Industries drew a fresh Outperform initiation on Friday from Bernstein. CF is a leading North American producer of nitrogen fertilizer and ammonia. Its plants run on relatively inexpensive U.S. natural gas, which gives it a cost advantage over producers that rely on pricier gas overseas.
Shares traded near $114.55 during Friday's session, down about 3.28%, giving CF a market capitalization near $17.6 billion. The 52-week range runs from $75.42 to $141.96, the trailing price-to-earnings multiple sits at a low 8.49, and the dividend yield is near 2%.
This is a contrarian call relative to the panel. Consensus reads hold, with four bullish, six neutral, and two bearish ratings among 12 tracked firms. The average price target of $125.08 implies roughly 9% upside, and Wells Fargo's Michael Sison holds the high target of $150.
Risks: Fertilizer is a commodity business, and earnings swing with nitrogen prices and natural-gas costs. RBC Capital's Andrew Wong cut his target to $115 from $125 on July 17 while holding Sector Perform. Crop prices, farmer affordability, and progress on the company's low-carbon ammonia projects all remain factors to monitor.
Viking Holdings (VIK) – StoneX Initiates at Buy
Viking Holdings drew a fresh Buy initiation on Friday from StoneX. Viking operates river and ocean cruises aimed at older, affluent travelers, a customer base that has historically been less sensitive to interest rates and economic slowdowns than the mass-market cruise audience.
Shares traded near $80.05 during Friday's session, up about 0.67%, giving Viking a market capitalization near $36 billion. The 52-week range runs from $56.37 to $110.09, and the trailing price-to-earnings multiple sits at 26.53.
Consensus reads buy, with 12 bullish, two neutral, and one bearish rating among 15 tracked firms. The average price target of $105.67 implies roughly 32% upside, and the panel high sits at $128.
Risks: Mizuho's Ben Chaiken holds Underperform at $82, and Truist's Patrick Scholes trimmed his target to $98 from $102 on September 24 while holding Buy. Fuel costs, new-ship delivery schedules, and any slowdown in premium travel demand all remain factors to monitor.
Found this helpful? Share it with others.